RSV vaccination in immunocompromised adults
Background: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in immunocompromised adults, including solid organ and hematopoietic stem cell transplant recipients. Following the 2023 licensure of three RSV vaccines for older adults, increasing numbers of immunocom...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2026-08-01
|
| Reeks: | International Journal of Infectious Diseases |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S1201971226004194 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
